MultiCare Health System has received word from the National Comprehensive Cancer Network’s Oncology Research Program that it has qualified to be part of its Affiliate Research Project that will allow it to be on the leading edge of cancer treatment research.
“Our patients will have access to the most innovative and cutting-edge therapies available, and in so doing they will be making an important contribution to the global fight against cancer,” Dr. John A. Keech. “MultiCare Regional Cancer Center’s qualified designation with the NCCN ARP significantly enhances and expands our already robust clinical trial access that is established with the Seattle Cancer Care Alliance and the Northwest Community Clinical Oncology Program. Our new NCCN ARP designation affords us an opportunity to offer our patients opportunities to participate in research that previously have been available only at the original NCCN institutions, so that they can receive the highest quality of cancer care right here in the South Sound.”
MultiCare will now have access to new and innovative cancer drugs for their patients in collaboration with other member institutions.